{"id":7253,"date":"2009-01-15T17:25:00","date_gmt":"2009-01-15T17:25:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/life-after-cnto411-blog-for-michae\/"},"modified":"2019-02-21T01:23:54","modified_gmt":"2019-02-21T01:23:54","slug":"life-after-cnto411-blog-for-michae","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/life-after-cnto411-blog-for-michae\/","title":{"rendered":"Life After CNTO411 Blog for Michael Parks: Pitch360"},"content":{"rendered":"

\"\"<\/a>You may have noticed that Centocor’s corporate blog, CNTO411, has been dormant for several months, which I pointed out previously (see “New Year’s Resolutions for Pharma Marketers<\/a>” and “Corporate Blog” is an Oxymoron<\/a>“). But what you may NOT know is that the creator of that blog, Michael Parks, no longer works for Centocor, although he is still listed as the Editor (see here<\/a>).<\/p>\n

Parks, nevertheless, is moving on with his new life as a “PR hack” for hire — not that there’s anything wrong with that — for small companies. His new company, Pitch360<\/a>, “gives a big voice to small companies,” says Parks. I wish Michael the best of luck in his new endeavor and not just because he treated me to a BBQ dinner at Dave’s Famous BBQ — wait, I think we went Dutch!<\/p>\n

Any way, here’s the press release:<\/p>\n

Michael Parks, former Vice President of Corporate Communications for Centocor, Inc., an operating company of Johnson & Johnson (J&J) today announced the launch of a public relations consultancy, Pitch360 Incorporated (www.pitch360inc.com<\/a>) . Pitch360 is a public relations, marketing communications, and issues management consultancy that leverages its vast pharmaceutical and biotechnology experience to transform the way companies communicate to their customers, key stakeholders, and mainstream and social media.<\/p>\n

\u201cAfter nearly 15 years serving the pharma industry and growing from that experience, I wanted to design a consultancy that specifically caters to the next generation of companies that promise breakthrough therapies for patients,\u201d said Michael Parks, Founder and President of Pitch360 Inc. \u201cIn particular, small companies can now bypass the trial-and-error process of their predecessors and immediately put breakthrough strategies to work for their business.\u201d<\/p>\n

Created with the changing needs of the industry in mind, Pitch360 uses its relationships with a wide variety of stakeholders in the pharmaceutical and biotech industry to stay ahead of \u2018status quo\u2019 thinking so that they can bring forward ideas that rise above that of their competition. Through well established networks of healthcare providers, experts in government, regulatory and policy matters; creative media talent, as well the healthcare, business, mainstream and social media; Pitch360 has the tools and experience necessary to provide breakthrough strategies that companies can implement to deliver on their business objectives.<\/p>\n

\u201cIn today\u2019s economy, companies are looking for value and innovation,\u201d said Mr. Parks, \u201cPitch360 provides affordable communications solutions using breakthrough strategies that will deliver outstanding results.\u201d<\/p>\n

Pitch360 has a wide variety of services available for companies and not-for-profit groups, including strategic counseling, issues management, and investor relations and delivers these services with outstanding customer service and support. Pitch360 provides specialty services for companies of all sizes.<\/p>\n

Michael will be a guest on Pharma Marketing Talk<\/a> in February. Stay tuned for that.<\/p>\n","protected":false},"excerpt":{"rendered":"

You may have noticed that Centocor’s corporate blog, CNTO411, has been dormant for several months, which I pointed out previously (see “New Year’s Resolutions for Pharma Marketers” and “Corporate Blog” is an Oxymoron“). But what you may NOT know is that the creator of that blog, Michael Parks, no longer works for Centocor, although he […]<\/p>\n","protected":false},"author":2,"featured_media":9108,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12],"tags":[979,1001],"topic":[],"acf":[],"yoast_head":"\nLife After CNTO411 Blog for Michael Parks: Pitch360 - Pharma Marketing Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/life-after-cnto411-blog-for-michae\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Life After CNTO411 Blog for Michael Parks: Pitch360 - Pharma Marketing Network\" \/>\n<meta property=\"og:description\" content=\"You may have noticed that Centocor’s corporate blog, CNTO411, has been dormant for several months, which I pointed out previously (see “New Year’s Resolutions for Pharma Marketers” and “Corporate Blog” is an Oxymoron“). But what you may NOT know is that the creator of that blog, Michael Parks, no longer works for Centocor, although he […]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/life-after-cnto411-blog-for-michae\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Marketing Network\" \/>\n<meta property=\"article:published_time\" content=\"2009-01-15T17:25:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-02-21T01:23:54+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2009\/01\/michael_parks.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"129\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pharma Guy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pharma Guy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/life-after-cnto411-blog-for-michae\/\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/life-after-cnto411-blog-for-michae\/\",\"name\":\"Life After CNTO411 Blog for Michael Parks: Pitch360 - Pharma Marketing Network\",\"isPartOf\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\"},\"datePublished\":\"2009-01-15T17:25:00+00:00\",\"dateModified\":\"2019-02-21T01:23:54+00:00\",\"author\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\"},\"breadcrumb\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/life-after-cnto411-blog-for-michae\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/life-after-cnto411-blog-for-michae\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/life-after-cnto411-blog-for-michae\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Life After CNTO411 Blog for Michael Parks: Pitch360\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\",\"name\":\"Pharma Marketing Network\",\"description\":\"Pharma Marketing Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\",\"name\":\"Pharma Guy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/\",\"url\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"contentUrl\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"caption\":\"Pharma Guy\"},\"description\":\"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Life After CNTO411 Blog for Michael Parks: Pitch360 - Pharma Marketing Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/life-after-cnto411-blog-for-michae\/","og_locale":"en_US","og_type":"article","og_title":"Life After CNTO411 Blog for Michael Parks: Pitch360 - Pharma Marketing Network","og_description":"You may have noticed that Centocor’s corporate blog, CNTO411, has been dormant for several months, which I pointed out previously (see “New Year’s Resolutions for Pharma Marketers” and “Corporate Blog” is an Oxymoron“). But what you may NOT know is that the creator of that blog, Michael Parks, no longer works for Centocor, although he […]","og_url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/life-after-cnto411-blog-for-michae\/","og_site_name":"Pharma Marketing Network","article_published_time":"2009-01-15T17:25:00+00:00","article_modified_time":"2019-02-21T01:23:54+00:00","og_image":[{"width":129,"height":200,"url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2009\/01\/michael_parks.jpg","type":"image\/jpeg"}],"author":"Pharma Guy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pharma Guy","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/life-after-cnto411-blog-for-michae\/","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/life-after-cnto411-blog-for-michae\/","name":"Life After CNTO411 Blog for Michael Parks: Pitch360 - Pharma Marketing Network","isPartOf":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website"},"datePublished":"2009-01-15T17:25:00+00:00","dateModified":"2019-02-21T01:23:54+00:00","author":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1"},"breadcrumb":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/life-after-cnto411-blog-for-michae\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/life-after-cnto411-blog-for-michae\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/life-after-cnto411-blog-for-michae\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/"},{"@type":"ListItem","position":2,"name":"Life After CNTO411 Blog for Michael Parks: Pitch360"}]},{"@type":"WebSite","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/","name":"Pharma Marketing Network","description":"Pharma Marketing Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1","name":"Pharma Guy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/","url":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","contentUrl":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","caption":"Pharma Guy"},"description":"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/"}]}},"_links":{"self":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/7253"}],"collection":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/comments?post=7253"}],"version-history":[{"count":1,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/7253\/revisions"}],"predecessor-version":[{"id":9109,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/7253\/revisions\/9109"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media\/9108"}],"wp:attachment":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media?parent=7253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/categories?post=7253"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/tags?post=7253"},{"taxonomy":"topic","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/topic?post=7253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}